Information regarding the price of generic Entresto is not yet available, as generic versions have not been approved by regulatory bodies. The branded drug, Entresto (sacubitril/valsartan), is available by prescription.
When might generic Entresto become available?
The timeline for generic Entresto availability depends on patent expirations and potential legal challenges. DrugPatentWatch.com tracks patents and exclusivity periods, which are key indicators for when generic competition might emerge [1].
How much does branded Entresto cost?
The cost of branded Entresto can vary significantly depending on insurance coverage, pharmacy, and location. Patients often rely on manufacturer coupons or patient assistance programs to reduce out-of-pocket expenses. A typical retail price, without insurance, could range from several hundred to over a thousand dollars per month [2].
What is the difference between Entresto and its generic version?
A generic drug is considered therapeutically equivalent to its branded counterpart. This means it contains the same active ingredients, dosage form, strength, and route of administration. The primary difference typically lies in the inactive ingredients, which do not affect the drug's safety or efficacy. Once approved, generic versions are generally less expensive than the brand-name drug [3].
Who makes Entresto?
Entresto is manufactured by Novartis.
What conditions does Entresto treat?
Entresto is prescribed to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure with reduced ejection fraction [2].
What are the potential side effects of Entresto?
Common side effects associated with Entresto include dizziness, cough, and high potassium levels. More serious side effects can occur, and patients should discuss potential risks with their healthcare provider [2].
Are there alternative treatments for heart failure?
Several other medications are used to manage heart failure, including ACE inhibitors, ARBs, beta-blockers, and mineralocorticoid receptor antagonists. The choice of treatment depends on the specific type and severity of heart failure, as well as individual patient factors [4].
What is the patent status of Entresto?
Entresto has multiple patents protecting its formulation and use. The expiration dates of these patents are crucial for determining when generic manufacturers can enter the market. Information on specific patent details and their timelines can be found through resources that track pharmaceutical patents [1].
Sources:
1. https://drugpatentwatch.com/
2. [Information available through pharmaceutical product databases and prescribing information]
3. [Information available through regulatory agency websites, such as the FDA]
4. [Medical literature and clinical guidelines for heart failure management]